Financials

  • Market Capitalization 9.33 B
  • Employee 253
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-23.27
ratio cours/chiffre d'affaires
148.57

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
926
NUVL
Nuvalent, Inc. - Class A Common Stock
123.96 USD0.00%+0.18%+0.45%+30.55%9.79 B USD
941
CORT
Corcept Therapeutics Incorporated - Common Stock
88.90 USD-1.74%-3.53%+6.88%+21.17%9.54 B USD
979
PRAX
Praxis Precision Medicines, Inc. - Common Stock
319.42 USD-2.52%-4.46%+20.57%+513.33%8.91 B USD
983
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
54.64 USD-0.53%-35.18%-26.09%-24.24%9.03 B USD

Nouvelles